SUBJECT INDEX - BC Cancer Agency
SUBJECT INDEX - BC Cancer Agency
SUBJECT INDEX - BC Cancer Agency
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Index to volume 5 (no. 1-12) (2002) for health professionals who care for cancer patients<br />
VOLUME 5 January-December 2002<br />
No. 1 ............................................January No. 7..................................................July<br />
No. 2 ............................................February No. 8 .................................................August<br />
No. 3 ............................................ March No. 9 .................................................September<br />
No. 4 ............................................April No. 10 ...............................................October<br />
No. 5 ............................................May No. 11 ...............................................November<br />
No. 6 ............................................June No. 12 ...............................................December<br />
A<br />
(The) American Society of Clinical Oncology<br />
(ASCO) 38 th Annual Meeting continuing<br />
education, vol 5 (5)<br />
Amifostine benefit drug list, vol 5 (8); patient<br />
education update, vol 5 (11); drug update,<br />
vol 5 (11); benefit drug list, vol 5 (12)<br />
Anastrozole, benefit drug list, vol 5 (7)<br />
Aventis Pharma, Partnership with<br />
acknowledgment of support, vol 5 (7)<br />
B<br />
<strong>BC</strong>CA Annual <strong>Cancer</strong> Conference continuing<br />
education, vol 5 (8); continuing education,<br />
vol 5 (9); continuing education, vol 5 (10);<br />
continuing education, vol 5 (11)<br />
<strong>BC</strong>CA Nursing Resources, increasing access<br />
communities oncology network, vol 5 (11)<br />
<strong>BC</strong> Palliative Care Benefit Program focus on,<br />
vol 5 (4)<br />
<strong>BC</strong> Palliative Care Drug Formulary focus on,<br />
vol 5 (4)<br />
Bexarotene benefit drug list, vol 5 (7); patient<br />
education update, vol 5 (10)<br />
BRAJCEF pre-printed orders, vol 5 (6); protocol<br />
update, vol 5 (10); pre-printed order update,<br />
vol 5 (11)<br />
<strong>SUBJECT</strong> <strong>INDEX</strong><br />
BRAJCEF-G protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11)<br />
BRAJTAM protocol update, vol 5 (7)<br />
BRAVANAS protocol update, vol 5 (7)<br />
BRAVBT protocol update, vol 5 (7)<br />
BRAVCAD protocol update, vol 5 (7); preprinted<br />
order update, vol 5 (10); list of new<br />
and revised protocols, vol 5 (11)<br />
BRAVLET protocol update, vol 5 (7)<br />
BRAVNAV protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11)<br />
BRAVTAM protocol update, vol 5 (7)<br />
BRAVTAX protocol update, vol 5 (7)<br />
BRAVCAP protocol update, vol 5 (3)<br />
BRAVDOC pre-printed order update, vol 5 (2);<br />
list of new and revised protocols, vol 5 (11)<br />
BRAVDOC7 list of new and revised protocols,<br />
vol 5 (11); list of new and revised protocols,<br />
vol 5 (12)<br />
BRAVEXE list of new and revised protocols, vol<br />
5 (11)<br />
BRAVMEG list of new and revised protocols, vol<br />
5 (12)<br />
BRAVTAX protocol update, vol 5 (5)<br />
(U)BRAVTR pre-printed order update, vol 5 (6);<br />
list of new and revised protocols, vol 5 (11)<br />
British Columbia <strong>Cancer</strong> <strong>Agency</strong> � Provincial Systemic Therapy Program Update � Index to Vol. 5 (No. 1-12) 2002
BRAVTRAP protocol update, vol 5 (5); preprinted<br />
order update, vol 5 (7); pre-printed<br />
order update, vol 5 (9); pre-printed order<br />
update, vol 5 (11)<br />
BRAVTRNAV pre-printed order update, vol 5<br />
(1); pre-printed order update, vol 5 (6); preprinted<br />
order update, vol 5 (11)<br />
Breast cancer cancer management manual, vol<br />
5 (12)<br />
BRINFCEF protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11)<br />
BRINFCEF-G protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11)<br />
British Columbia Oncology Nursing Group<br />
(<strong>BC</strong>ONG) Annual Conference continuing<br />
education, vol 5 (2)<br />
BRLACEF protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11)<br />
BRLACEF-G protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11)<br />
Busulfan injectable benefit drug list, vol 5 (11)<br />
C<br />
Cabergoline benefit drug list, vol 5 (11)<br />
Canadian Association of Nurses in Oncology<br />
(CANO) Annual Conference continuing<br />
education, vol 5 (7); continuing education,<br />
vol 5 (8); continuing education, vol 5 (9)<br />
Canadian Bioethics Society 14 th Annual General<br />
Meeting and Conference continuing<br />
education, vol 5 (3)<br />
Capecitabine benefit drug list, vol 5 (7)<br />
Carboplatin focus on carboplatin<br />
hypersensitivity, vol 5 (10)<br />
Chlorambucil patient education update, vol 5<br />
(9); cancer drug manual, vol 5 (9)<br />
Cisplatin benefit drug list, vol 5 (7)<br />
CNCAB list of new and revised protocols, vol 5<br />
(11)<br />
CNCCV protocol update, vol 5 (9); pre-printed<br />
order update, vol 5 (9)<br />
CNMODPCV protocol update, vol 5 (9); preprinted<br />
order update, vol 5 (9); list of new<br />
and revised protocols, vol 5 (11)<br />
<strong>SUBJECT</strong> <strong>INDEX</strong><br />
CNTEMOZ pre-printed order update, vol 5 (9);<br />
list of new and revised protocols, vol 5 (11);<br />
list of new and revised protocols, vol 5 (12)<br />
Communities Oncology Network Pharmacy<br />
Survey communities oncology network, vol 5<br />
(6)<br />
Contact phone numbers communities oncology<br />
network, vol 5 (11)<br />
Cytotoxic contamination focus on safe handling<br />
of cytotoxics, vol 5 (7);<br />
D<br />
Docetaxel drug update, vol 5 (2); benefit drug<br />
list, vol 5 (7); benefit drug list, vol 5 (11)<br />
Doxorubicin cancer drug manual, vol 5 (12)<br />
E<br />
Education Resource Nurses communities<br />
oncology network, vol 5 (5)<br />
Emergency Aid (EA) Program focus on, vol 5 (4)<br />
ENAVD pre-printed order update, vol 5 (6)<br />
Extravasation of chemotherapy, policy provincial<br />
systemic therapy program policies, vol 5 (8)<br />
F<br />
Filgrastim (G-CSF) reimbursement guidelines<br />
communities oncology network, vol 5 (12)<br />
Financial Aids for <strong>Cancer</strong> Patients focus on,<br />
vol 5 (2)<br />
Fludarabine benefit drug list, vol 5 (11); patient<br />
education update, vol 5 (11)<br />
Free samples, policy on use of provincial<br />
systemic therapy program policies, vol 5 (8)<br />
G<br />
Gemcitabine benefit drug list, vol 5 (7); benefit<br />
drug list, vol 5 (11)<br />
GIAVCAP protocol update, vol 5 (7)<br />
(U)GIAVCAP protocol update, vol 5 (3),<br />
GIFFAD pre-printed order update, vol 5 (2);<br />
protocol update, vol 5 (10); pre-printed order<br />
update, vol 5 (10)<br />
British Columbia <strong>Cancer</strong> <strong>Agency</strong> � Provincial Systemic Therapy Program Update � Index to Vol. 5 (No. 1-12) 2002
GIFOLFIRI list of new and revised protocols, vol<br />
5 (12)<br />
(U)GIFOLFOX protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11); list of new<br />
and revised protocols, vol 5 (12)<br />
GIFUA protocol update, vol 5 (8)<br />
GIFUFA protocol update, vol 5 (10)<br />
GIFUINF pre-printed order update, vol 5 (6);<br />
pre-printed order update, vol 5 (9)<br />
(U)GIFUIP pre-printed order update, vol 5 (1);<br />
pre-printed order update, vol 5 (3)<br />
GIFUR2 protocol update, vol 5 (10)<br />
GIFUR3 list of new and revised protocols, vol 5<br />
(12)<br />
GIGAI protocol update, vol 5 (7); protocol<br />
update, vol 5 (10)<br />
GIIRFUFA pre-printed order update, vol 5 (1);<br />
pre-printed order update, vol 5 (6); preprinted<br />
order update, vol 5 (9)<br />
(U)GIIRINALT list of new and revised protocols,<br />
vol 5 (11)<br />
GIPGEM pre-printed order update, vol 5 (7)<br />
GIRAI protocol update, vol 5 (10)<br />
GIRALT pre-printed order update, vol 5 (2)<br />
GIRFF protocol update, vol 5 (10)<br />
Gleevec® see imatinib<br />
Glutamine drug update, vol 5 (7)<br />
GOCXRADC pre-printed order update, vol 5 (1);<br />
protocol update, vol 5 (3); pre-printed order<br />
update, vol 5 (7)<br />
(U)GOCXCAT protocol update, vol 5 (7)<br />
GOENDCAT protocol update, vol 5 (7)<br />
GOOVCATM protocol update, vol 5 (7)<br />
GOOVCATR protocol update, vol 5 (7); list of<br />
new and revised protocols, vol 5 (11)<br />
GOOVCATX protocol update, vol 5 (7)<br />
GOOVGEM list of new and revised protocols,<br />
vol 5 (11)<br />
GOOVTAX3 protocol update, vol 5 (7)<br />
Goserelin patient education update, vol 5 (11)<br />
GOSMCC2 protocol update, vol 5 (7)<br />
(U)GUAJPG protocol update, vol 5 (7); protocol<br />
update, vol 5 (9); protocol update, vol 5 (10)<br />
<strong>SUBJECT</strong> <strong>INDEX</strong><br />
GUAVPG protocol update, vol 5 (7); protocol<br />
update, vol 5 (9); pre-printed order update,<br />
vol 5 (9); protocol update, vol 5 (10)<br />
GU<strong>BC</strong>V protocol update, vol 5 (4); protocol<br />
update, vol 5 (5); pre-printed order update,<br />
vol 5 (7); protocol update, vol 5 (9); protocol<br />
update, vol 5 (10)<br />
GUBPV protocol update, vol 5 (4)<br />
GUBEP protocol update, vol 5 (2)<br />
GUBVAL protocol update, vol 5 (8); list of new<br />
and revised protocols, vol 5 (11)<br />
GUCMV protocol update, vol 5 (4)<br />
GUEP protocol update, vol 5 (2)<br />
(U)GUGEMCIS protocol update, vol 5 (4);<br />
protocol update, vol 5 (5)<br />
Guidelines for the Care of Radiation Skin<br />
Reactions supportive care, vol 5 (3)<br />
Guidelines for Maximum Lifetime Doses of<br />
Anthracyclines in Adults drug update, vol 5<br />
(6)<br />
GUMVAC pre-printed order update, vol 5 (6)<br />
GUPDOC list of new and revised protocols, vol<br />
5 (11)<br />
GUPM protocol update, vol 5 (4); pre-printed<br />
order update, vol 5 (6)<br />
GUPMX protocol update, vol 5 (4); protocol<br />
update, vol 5 (9); pre-printed order update,<br />
vol 5 (9); pre-printed order update, vol 5<br />
(10); list of new and revised protocols, vol 5<br />
(12)<br />
GUSCPE protocol update, vol 5 (9)<br />
GUSCCAVE protocol update, vol 5 (9)<br />
(U)GUTAXGEM list of new and revised<br />
protocols, vol 5 (11)<br />
GUVEIP protocol update, vol 5 (5); pre-printed<br />
order update, vol 5 (9)<br />
H<br />
HNCARFU protocol update, vol 5 (9)<br />
HNCMT pre-printed order update, vol 5 (1); preprinted<br />
order update, vol 5 (9)<br />
HNFUFA pre-printed order update, vol 5 (1)<br />
British Columbia <strong>Cancer</strong> <strong>Agency</strong> � Provincial Systemic Therapy Program Update � Index to Vol. 5 (No. 1-12) 2002
(U)HNRAMI protocol update, vol 5 (8); list of<br />
new and revised protocols, vol 5 (11); list of<br />
new and revised protocols, vol 5 (12)<br />
Hyaluronidase drug update, vol 5 (8)<br />
Hydromorphone Pharmacare Authorisation drug<br />
update, vol 5 (1)<br />
I<br />
Imatinib benefit drug list, vol 5 (7); patient<br />
education update, vol 5 (7)<br />
Interferon benefit drug list, vol 5 (8); alpha,<br />
patient education update, vol 5 (10); cancer<br />
drug manual, vol 5 (10); benefit drug list,<br />
vol 5 (11)<br />
Interim Contacts for CON related issues<br />
communities oncology network, vol 5 (5)<br />
International Society of Oncology Pharmacy<br />
Practitioners (ISOPP) VIII Symposium<br />
continuing education, vol 5 (3), continuing<br />
education, vol 5 (5)<br />
Intrathecal chemotherapy, policy on<br />
administration of provincial systemic therapy<br />
program policies, vol 5 (11)<br />
Iressa® see ZD 1839<br />
Irinotecan drug update, vol 5 (10); benefit drug<br />
list, vol 5 (11)<br />
K<br />
KSVB protocol update, vol 5 (5); pre-printed<br />
order update, vol 5 (6); protocol update, vol<br />
5 (9); pre-printed order update, vol 5 (9)<br />
J<br />
L<br />
Letrozole benefit drug list, vol 5 (7)<br />
Leuprolide patient education update, vol 5 (11)<br />
LHRH agonist benefit drug list, vol 5 (7); patient<br />
education update, vol 5 (8)<br />
(U)LKCMLI protocol update, vol 5 (7)<br />
LUALTL protocol update, vol 5 (9); pre-printed<br />
order update, vol 5 (9)<br />
<strong>SUBJECT</strong> <strong>INDEX</strong><br />
LUCAV protocol update, vol 5 (9); pre-printed<br />
order update, vol 5 (9)<br />
(U)LUCISDOC protocol update, vol 5 (9); list of<br />
new and revised protocols, vol 5 (11)<br />
LUCMT-1 protocol update, vol 5 (5)<br />
LUDOC protocol update, vol 5 (6); pre-printed<br />
order update, vol 5 (7); pre-printed order<br />
update, vol 5 (9); list of new and revised<br />
protocols, vol 5 (11)<br />
LUPAVESE protocol update, vol 5 (9); preprinted<br />
order update, vol 5 (9); protocol<br />
update, vol 5 (10)<br />
LUPAVESL protocol update, vol 5 (9); preprinted<br />
order update, vol 5 (9); protocol<br />
update, vol 5 (10)<br />
LUPE pre-printed order update, vol 5 (3);<br />
protocol update, vol 5 (6); pre-printed order<br />
update, vol 5 (9)<br />
(U)LUPG protocol update, vol 5 (6); protocol<br />
update, vol 5 (9); protocol update, vol 5 (10);<br />
list of new and revised protocols, vol 5 (11)<br />
LYABVD protocol update, vol 5 (4); protocol<br />
update, vol 5 (5); pre-printed order update,<br />
vol 5 (6)<br />
LYCCOP protocol update, vol 5 (9); pre-printed<br />
order update, vol 5 (10)<br />
LYCHOP protocol update, vol 5 (9); pre-printed<br />
order update, vol 5 (9); list of new and<br />
revised protocols, vol 5 (11)<br />
LYCHOP-R pre-printed order update, vol 5 (1);<br />
protocol update, vol 5 (2); pre-printed order,<br />
vol 5 (5); pre-printed order update, vol 5 (7);<br />
focus on the sequence of administration of<br />
rituximab and chop, vol 5 (8); protocol<br />
update, vol 5 (9); pre-printed order update,<br />
vol 5 (9); pre-printed order update, vol 5 (11)<br />
LYCOPP protocol update, vol 5 (9)<br />
LYCSPA protocol update, vol 5 (9)<br />
LYCVP protocol update, vol 5 (4); protocol<br />
update, vol 5 (9); pre-printed order update,<br />
vol 5 (9)<br />
LYECV list of new and revised protocols, vol 5<br />
(11)<br />
LYFLU protocol update, vol 5 (2); list of new and<br />
revised protocols, vol 5 (11)<br />
British Columbia <strong>Cancer</strong> <strong>Agency</strong> � Provincial Systemic Therapy Program Update � Index to Vol. 5 (No. 1-12) 2002
LYGDP list of new and revised protocols, vol 5<br />
(11); list of new and revised protocols, vol 5<br />
(12)<br />
LYICE list of new and revised protocols, vol 5<br />
(11)<br />
LYIT list of new and revised protocols, vol 5 (11)<br />
(U)LYMFBEX protocol update, vol 5 (7);<br />
protocol update, vol 5 (10)<br />
LYMPHOMA pre-printed order, vol 5 (5)<br />
LYODBEP protocol update, vol 5 (9); pre-printed<br />
order update, vol 5 (9)<br />
LYPALL list of new and revised protocols, vol 5<br />
(11)<br />
LYRITUX pre-printed order update, vol 5 (7)<br />
LYTHALID protocol update, vol 5 (10)<br />
M<br />
Melphalan cancer drug manual, vol 5 (12)<br />
Mitomycin drug update, vol 5 (10); cancer drug<br />
manual, vol 5 (10)<br />
Mitoxantrone drug update, vol 5 (2); cancer drug<br />
manual, vol 5 (12)<br />
Mucositis, oral nursing practice tips, vol 5 (9)<br />
MYHDC pre-printed order update, vol 5 (5);<br />
protocol update, vol 5 (8); pre-printed order<br />
update, vol 5 (9)<br />
N<br />
Needs Assessment for CON Pharmacists<br />
communities oncology network pharmacy<br />
survey, vol 5 (6)<br />
Nursing responsibility for oral assessment of<br />
patients on fluorouracil –based GI<br />
chemotherapy nursing practice update, vol 5<br />
(10)<br />
O<br />
Oxaliplatin cancer drug manual, vol 5 (12)<br />
<strong>SUBJECT</strong> <strong>INDEX</strong><br />
P<br />
Paclitaxel benefit drug list, vol 5 (11)<br />
Part-time on-line MSc in oncology and palliative<br />
care continuing education, vol 5 (12)<br />
Pharmacy Communities Oncology Network<br />
(CON) Educators continuing education, vol 5<br />
(1)<br />
Pharmacy professional development, survey<br />
results communities oncology network, vol 5<br />
(11)<br />
Physician coverage for medical emergencies<br />
during delivery of selected chemotherapy<br />
drugs provincial systemic therapy program<br />
policies, vol 5 (10)<br />
Prostate cancer patient information patient<br />
education, vol 5 (3)<br />
Prostate specific antigen (PSA) screening<br />
<strong>Cancer</strong> Management Manual, vol 5 (1)<br />
Provincial Drug Information Specialist, new<br />
provincial drug information, vol 5 (10)<br />
PUM pre-printed order update, vol 5 (6)<br />
British Columbia <strong>Cancer</strong> <strong>Agency</strong> � Provincial Systemic Therapy Program Update � Index to Vol. 5 (No. 1-12) 2002<br />
Q<br />
R<br />
Retirement of CON Vice President communities<br />
oncology network, vol 5 (4)<br />
S<br />
SAAJA list of new and revised protocols, vol 5<br />
(11)<br />
(U)SAAVGI protocol update, vol 5 (7)<br />
SAVAC pre-printed order update, vol 5 (7);<br />
protocol update, vol 5 (9); pre-printed order<br />
update, vol 5 (9)<br />
SAVACM protocol update, vol 5 (9); pre-printed<br />
order update, vol 5 (9)
SCHYPCAL protocol update, vol 5 (1)<br />
SCPAINSU protocol update, vol 5 (4); preprinted<br />
order update, vol 5 (6)<br />
Skin-melanoma cancer management manual,<br />
vol 5 (12)<br />
(U)SMAJIFN protocol update, vol 5 (8); protocol<br />
update, vol 5 (10); list of new and revised<br />
protocols, vol 5 (11)<br />
SMTAM protocol update, vol 5 (1)<br />
SMTV protocol update, vol 5 (1); protocol<br />
update, vol 5 (5); pre-printed order, vol 5 (5)<br />
Special access programme, changes drug<br />
update, vol 5 (11)<br />
St. John’s Wort drug update, vol 5 (10)<br />
Sufentanil for incident pain supportive care,<br />
vol 5 (4); pre-printed order, vol 5 (5)<br />
Symptom management, presentation on<br />
continuing education, vol 5 (9); continuing<br />
education, vol 5 (10); continuing education,<br />
vol 5 (11)<br />
T<br />
Tamoxifen benefit drug list, vol 5 (7)<br />
Targretin® see bexarotene<br />
Temozolomide benefit drug list, vol 5 (11)<br />
Thalidomide Patient Handout patient education<br />
update, vol 5 (6); patient education, vol 5<br />
(10)<br />
Trastuzumab benefit drug list, vol 5 (11)<br />
U<br />
(U)BRAJACT protocol update, vol 5 (7)<br />
(U)BRAVTR pre-printed order update, vol 5 (6)<br />
BRAVTRAP protocol update, vol 5 (7)<br />
(U)GIAVCAP protocol update, vol 5 (2)<br />
(U)GIFOLFOX protocol update, vol 5 (10); preprinted<br />
order update, vol 5 (11)<br />
(U)GIFUIP pre-printed order update, vol 5 (1)<br />
(U)GIIRINALT list of new and revised protocols,<br />
vol 5 (11)<br />
(U)GOCXCAT protocol update, vol 5 (7)<br />
<strong>SUBJECT</strong> <strong>INDEX</strong><br />
(U)GUAJPG protocol update, vol 5 (7); protocol<br />
update, vol 5 (9); protocol update, vol 5 (10)<br />
(U)GUGEMCIS protocol update, vol 5 (4);<br />
protocol update, vol 5 (5)<br />
(U)HNRAMI protocol update, vol 5 (8)<br />
(U)LKCMLI protocol update, vol 5 (7)<br />
(U)LUCISDOC protocol update, vol 5 (9); list of<br />
new and revised protocols, vol 5 (11)<br />
(U)LUPG protocol update, vol 5 (6); protocol<br />
update, vol 5 (9)<br />
(U)LYMFBEX protocol update, vol 5 (7)<br />
(U)SAAVGI protocol update, vol 5 (7)<br />
(U)SMAJIFN protocol update, vol 5 (8); protocol<br />
update, vol 5 (10)<br />
V<br />
Valrubicin benefit drug list, vol 5 (8); patient<br />
education update, vol 5 (11)<br />
Vinblastine route of administration drug update,<br />
vol 5 (5)<br />
Vincristine, change in preparation for IV push<br />
use drug update, vol 5 (9)<br />
W<br />
Website access, improved website update, vol 5<br />
(4)<br />
Wydase® see hyaluronidase<br />
Z<br />
ZD 1839 patient education update, vol 5 (8);<br />
drug update, vol 5 (8)<br />
Zolendronic acid drug update, vol 5 (2)<br />
British Columbia <strong>Cancer</strong> <strong>Agency</strong> � Provincial Systemic Therapy Program Update � Index to Vol. 5 (No. 1-12) 2002
Change language